Abstract
Objective: To analyze the effectiveness of topical morphine in controlling local pain and promoting comfort in patients with neoplastic wounds in the breast, head, or neck. Method: A randomized, double-blind, phase II clinical trial conducted in a single center. The study aims to include 106 patients with malignant neoplastic wounds in these regions, over 18 years of age, with a minimum score of three on the numerical pain assessment scale (0-10). Expected results: The main outcomes evaluated will be average pain intensity, average pain relief, comfort score, systemic morphine dosage, and incidence/classification of adverse events.Registration: ClinicalTrials.gov (NCT05800834).

This publication has 20 references indexed in Scilit: